Seraseq® Pharmacogenomics DNA Mix

Pharmacogenomics is revolutionizing the way medications are prescribed, enabling the development of personalized treatment plans tailored to an individual’s genetic makeup. Reference materials are critical in pharmacogenomics, as they provide standardized benchmarks for validating and ensuring the accuracy of genetic tests.

Targeted for Pharmacogenomics Genetic Testing: Contains variants in 13 genes linked to adverse reaction to specific pharmacological therapies.

Comprehensive Variant Coverage: Includes 79 clinically-relevant mutations, all classified as pathogenic or likely pathogenic according to AMP recommendations, including a mix of AMP Tier 1 and hard-to-source Tier 2 variants.